Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

LiDCO Extends Collaboration With BD

16 Apr 2009 07:00

RNS Number : 6366Q
LiDCO Group Plc
15 April 2009
 



Press Release 

16 April 2009

LiDCO Group Plc

("LiDCO" or "the Company")

LiDCO extends collaboration with BD

LiDCO Group Plc (AIM: LID), the cardiovascular monitoring company, today has extended its exclusive collaboration with BD (Becton, Dickinson and Company), a leading global medical technology company dedicated to helping all people live healthy lives (see www.bd.com).

In June 2007, LiDCO signed an exclusive UK marketing collaboration with Becton, Dickinson U.K. Limited. LiDCO today announces the expansion of this exclusive collaboration with BD. Under the amended and restated terms of the agreement, LiDCO and BD will extend their exclusive marketing collaboration to include additional territories. The collaboration provides that BD Medical - Medical Surgical Systems regional sales teams will provide sales and marketing support for LiDCO products in territories additional to the UK. This marketing collaboration will result in an enhanced product offering for BD's customers as well as superior sales coverage for both LiDCO and LiDCO's network of distributors. 

In a separate agreement, LiDCO have entered an exclusive distribution and sales relationship for the LiDCOrapid Monitor with BD in Japan. This relationship will result in an enhanced product offering for BD customers, as well as improved access to LiDCO's technology by Japanese clinicians and patients. 

Dr Terry O'Brien, Chief Executive of LiDCO, commenting on the agreements stated: "This licensing arrangement in Japan and expansion of our marketing collaboration with a major corporation of the stature of BD further enhances our capabilities to provide our acute care customers with the best possible products and services to improve outcomes and reduce complications such as infections. We are very pleased to share a commitment with BD towards expanding access to innovative technologies that improve outcomes in the critically ill." 

Hideyuki Ashikaga, President, BD in Japan stated:

"BD designs and markets innovative products that address significant healthcare problems and deliver demonstrably higher benefits to patients, healthcare workers and researchers. Collaborating with LiDCO, an innovative company in an important healthcare market, will reinforce our capabilities to serve that market, in line with our corporate purpose of 'Helping all people live healthy lives'".

- ENDS -

For more information please contact:

LiDCO Group Plc

Terry O'Brien - Chief Executive

John Rowland - Company Secretary

Tel: +44 (0)20 7749 1500

www.lidco.com

FinnCap

Geoff Nash/ Stephen Norcross/

Marc Young 

+44 (0)20 7600 1658

www.finncap.com 

Media enquiries

Abchurch Communications

Heather Salmond / Stephanie Cuthbert / Simone Alves 

+44 (0)20 7398 7728

www.abchurch-group.com

About LiDCO Group Plc

LiDCO is a leading supplier of minimally invasive hemodynamic monitoring equipment and disposables. These are used primarily for the management of hospital patients requiring critical care or at major cardiovascular risk. LiDCO's computer-based technology significantly reduces the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London. LiDCO is based in the UK and its shares are traded on AIM. For more information please see www.lidco.com.

The Company's manufacturing facility is in Hoxton, London, and its current products are:

* LiDCOplus is a computer-based platform monitor used in the Intensive Care Unit for real-time continuous display of hemodynamic parameters including cardiac output, oxygen delivery and fluid-volume responsiveness (PPV% and SVV%)

* LiDCOrapid: our new cardiac output monitor designed specifically for use in the Operating Theatre for fluid and drug management at the point of care. The monitor features many clinical benefits. These enable acute-care physicians to get accurate and immediate feedback on the patient's fluid and hemodynamic status - a key measure of overall well-being during and after surgery. 

Early and rapid warning of change

Clear indication of therapeutic route: fluid or drug

Quantification of hemodynamic response, particularly stroke volume

Permits more effective delivery of fluids - the right amount at the right time

Advanced hemodynamic care has been shown to:

- Contribute to reduced morbidity and complications

- Reduce length of stay

- Reduce overall cost of care

* LiDCO single-patient-use disposables used in conjunction with the LiDCOplus and LiDCOrapid Monitors. 

* LiDCOview: an easy-to-use graphical display of historical LiDCOplus hemodynamic data. Both clinical researchers and routine users can view beat-to-beat hemodynamic data collected with the LiDCOplus. LiDCOviewSE is the standard version of this tool and is available for free, allowing anyone to download and access data from the LiDCOplus. LiDCOviewPRO is the Professional version, allowing users to analyse, export and report the LiDCOplus data. A free trial of LiDCOviewPRO is available for evaluation purposes prior to purchase

LiDCO Distribution Network:

The Company sells direct to hospitals in the UK, and elsewhere predominantly through a worldwide network of specialty critical care and anesthesia distributors.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIAMFTMMJBBML
Date   Source Headline
26th Jun 201212:40 pmRNSNotification of Major Interest in Shares
26th Jun 201212:40 pmRNSNotification of Major Interest in Shares
22nd Jun 20123:05 pmRNSExercise of Share Options
13th Jun 201211:55 amRNSResult of AGM
13th Jun 20127:00 amRNSLaunch of the LiDCOrapid monitor in Japan
12th Jun 20127:00 amRNSAnnual Report and Accounts and Notice of AGM
29th May 20127:00 amRNSLiDCOrapid Registration in Japan
10th May 20127:00 amRNSLiDCO technologies highlighted in NHS report
4th May 20127:00 amRNSExercise of Share Options
25th Apr 201210:40 amRNSGrant of share option
24th Apr 20127:00 amRNSPreliminary Results
28th Mar 20123:10 pmRNSExercise of Share Option
23rd Feb 20127:00 amRNSTrading Update and Notice of Results and AGM
8th Feb 20124:31 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
9th Jan 20127:00 amRNSLiDCO signs licensing agreement with CNSystems
12th Dec 20112:30 pmRNSExercise of a Share Option
7th Dec 20117:00 amRNSNHS Innovation Review
26th Oct 20117:00 amRNSInterim Results
12th Oct 20117:00 amRNSLiDCO monitor reduces surgical complications
24th Aug 201111:42 amRNSDirector/PDMR Shareholding
23rd Aug 20117:00 amRNSPre- close trading update
29th Jul 20117:00 amRNSExercise of Share Options
28th Jul 20117:00 amRNSNotice of Results
20th Jul 20113:25 pmRNSDirector's Holdings
14th Jul 20114:22 pmRNSExercise of a Share Option / Director's Holdings
14th Jul 20117:00 amRNSLiDCO signs agreement with ICU Medical, Inc
29th Jun 201111:45 amRNSResult of AGM
29th Jun 20117:00 amRNSJapanese Registration and Supply Agreement
1st Jun 20112:00 pmRNSPosting of Annual Report and Notice of AGM
17th May 20117:00 amRNSIssue of Equity
21st Apr 201111:45 amRNSDirector/PDMR Shareholding
20th Apr 20114:20 pmRNSDirector/PDMR Shareholding
19th Apr 20117:00 amRNSGrant of Share Options
18th Apr 20117:00 amRNSPreliminary Results
18th Apr 20117:00 amRNSDirectorate Change
15th Apr 201111:45 amRNSHolding(s) in Company
21st Mar 20117:00 amRNSDistribution Contract
24th Feb 20117:00 amRNSTrading Update and Notice of Results and AGM
26th Oct 20107:00 amRNSInterim Results
26th Oct 20107:00 amRNSInterim Results
15th Oct 20107:00 amRNSLiDCO monitors link with GE Healthcare
23rd Aug 20107:00 amRNSIssue of Equity
17th Aug 20102:50 pmRNSPre-Close Trading Update
12th Aug 20107:00 amRNSNotice of Results
12th Jul 20109:00 amRNSDirector's Share Transaction
2nd Jul 20107:00 amRNSLiDCO study day receives RCN accreditation
29th Jun 201011:40 amRNSResult of AGM
7th Jun 20101:30 pmRNS2010 Annual Report and Accounts & Notice of AGM
4th Jun 20107:00 amRNSDirectors dealings and grant of options
10th May 20107:00 amRNSMultiparameter monitoring reduces risk in surgery

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.